Clinical Trial Update: The Contribution of Lp-PLA2 Level to the Presence of Coronary Plaques in Patients With Non Alcoholic Fatty Liver Disease

View source ↗

Summary

A clinical trial update examining whether lipoprotein-associated phospholipase A2 (Lp-PLA2) levels are related to the presence of coronary plaques in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Nonalcoholic Fatty Liver Disease

Snippet

Sponsor: Ziv Hospital | Conditions: Nonalcoholic Fatty Liver Disease, Coronary Artery Disease | Status: UNKNOWN